1901 W. 47TH PLACE, KANSAS CITY, KS
Added to Russell 3000E®
Issued First U.S. Patent for Lead ADHD Asset CTx-1301
Receives Complete Response Letter from FDA for CTx-1301
Annual Report to Security Holders
Board Restructuring - Jeff Ervin and Jay Roberts Not Seeking Re-Election
Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for Lead ADHD Asset CTx-1301
Zhanpeng Jiang Appointed to Board of Directors of Cingulate Inc.
Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Q1
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload